NCT03801070

Brief Summary

This is a retrospective chart review study examining 1) demographic data such as age, sex, etiology of pancreatitis 2) clinical data including radiological characteristics of walled off pancreatic necrosis, walled off necrosis related admissions and readmission following endoscopic drainage, surgical or percutaneous procedures performed for the management of walled off pancreatic necrosis, and clinical outcomes following treatment of WON (including hospital readmissions, WON resolution, procedure complications, WON related death) 3) endoscopy data including indication for initial endoscopic drainage and subsequent endoscopic procedures performed for management of walled off necrosis (including additional EGD's, endoscopic drainage procedures, and/or necrosectomy)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 11, 2019

Completed
Last Updated

July 23, 2019

Status Verified

July 1, 2019

Enrollment Period

2 months

First QC Date

January 3, 2019

Last Update Submit

July 20, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Identify WON imaging characteristics on cat-scan

    Characteristics on cat-scan that are predictive of requiring multiple endoscopic procedures, percutaneous drainage, and/or surgical intervention for management of walled off pancreatic necrosis

    through study completion, an average of 260 days

  • Endoscopic course (total number and type of endoscopic treatments required for resolution of walled off necrosis, occurrence of treatment related complications)

    Imaging classification method to efficiently report these imaging characteristics

    through study completion, an average of 260 days

  • Clinical course (number of hospital readmissions during treatment, rates of walled off necrosis resolution, rates of walled off necrosis related death)

    Characteristics to develop a predictive model that will help to identify patients at high risk for requiring multiple endoscopic procedures, percutaneous drainage, and/or surgical intervention for management of walled off pancreatic necrosis.

    through study completion, an average of 260 days

Study Arms (2)

Less than median number necrosectomies

Group one includes patients who underwent less than median number necrosectomies

Procedure: endoscopic drainage of walled off pancreatic necrosis

At least the median number of necrosectomies

Group two includes patients who underwent at least the median number of necrosectomies

Procedure: endoscopic drainage of walled off pancreatic necrosis

Interventions

transmural drainage and mechanical debridement of solid debris (necrosectomy)

At least the median number of necrosectomiesLess than median number necrosectomies

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with organized collections that contain both solid and liquid debris and arise from necrotizing pancreatitis, referred to as walled off pancreatic necrosis (WON)

You may qualify if:

  • Patients over 18 years of age who underwent endoscopic drainage of walled off pancreatic necrosis
  • Patients who did not require further intervention (either surgical, percutaneous, or endoscopic) following endoscopic drainage
  • Patients who required further intervention for walled off pancreatic necrosis (either surgical, percutaneous, or endoscopic) following endoscopic drainage.
  • Patients who underwent percutaneous or surgical interventions prior to endoscopic drainage

You may not qualify if:

  • Pancreatic pseudocysts without any solid debris
  • Under 18 years of age at the time of endoscopic drainage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine in St Louis

St Louis, Missouri, 63010, United States

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2019

First Posted

January 11, 2019

Study Start

July 14, 2017

Primary Completion

September 1, 2017

Study Completion

December 1, 2017

Last Updated

July 23, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations